Hostname: page-component-857557d7f7-c8jtx Total loading time: 0 Render date: 2025-11-30T05:29:05.715Z Has data issue: false hasContentIssue false

CPK levels and neuroleptic malignant syndrome

Published online by Cambridge University Press:  02 January 2018

Sheelah James*
Affiliation:
Barnsley Hall Hospital, Stourbridge Road, Bromsgrove B61 0EX
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Correspondence
Copyright
Copyright © Royal College of Psychiatrists 1989 

References

Gledhill, R. F., Van Der Merwe, C. A., Greyling, M. et al (1988) Race-gender differences in serum creatine kinase activity: a study among South Africans. Journal of Neurology, Neurosurgery & Psychiatry, 51, 301304 Google Scholar
Goode, D. J., Meltzer, H. Y., Morretti, R. et al (1979) The relationship between wrist monitored motor activity and serum CPK activity in psychiatric in-patients. British Journal of Psychiatry, 135, 6266.Google Scholar
Kumar, A., Upadhyaya, G. L. & Trivedi, J. K. (1984) Serum CPK levels in schizophrenics and their first degree relatives. Indian Journal of Physiology and Pharmacology, 28, 128132.Google ScholarPubMed
Meltzer, H. Y. & Holy, P. A. (1974) Black-white differences in serum creatine phosphokinase (CPK) activity. Clinica Chimica Acta, 54, 215224.Google Scholar
Paasuke, R. T. & Brownell, A. K. (1986) Serum creatine kinase level as a screening test for susceptibility to malignant hyperthermia. Journal of the American Medical Association. 255, 769771.Google Scholar

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.